References

Luís Abegão Pinto, MD, PhD

Central Lisbon Hospital North. Visual Sciences Study Center, Faculty of Medicine, University of Lisbon, Portugal.

1.    Abegão Pinto L, Vandewalle E, Stalmans I. Disturbed correlation between arterial resistance and pulsatility in glaucoma patients. Acta Ophthalmol 2012;90(3):e214-20.

2.    Galassi F, Giambene B, Varriale R. Systemic vascular dysregulation and retrobulbar hemodynamics in normal-tension glaucoma. Invest Ophthalmol Vis Sci 2011;52(7):4467-71.

3.    Mroczkowska S, Benavente-Perez A, Negi A, et al. Primary open-angle glaucoma vs normal-tension glaucoma: the vascular perspective. JAMA Ophthalmol 2013;131(1):36-43.

4.    Flammer J, Konieczka K, Flammer AJ. The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J 2013;4(1):14.

5.    Wierzbowska J, Wierzbowski R, Stankiewicz A, et al. Cardiac autonomic dysfunction in patients with normal tension glaucoma: 24-h heart rate and blood pressure variability analysis. Br J Ophthalmol 2012;96(5):624-8.

6.    Pache M, Flammer J. A sick eye in a sick body? Systemic findings in patients with primary open-angle glaucoma. Surv Ophthalmol 2006;51(3):179-212.

7.    Schmidl D, Garhofer G, Schmetterer L. The complex interaction between ocular perfusion pressure and ocular blood flow - relevance for glaucoma. Exp Eye Res 2011;93(2):141-55.

8.    Resch H, Garhofer G, Fuchsjäger-Mayrl G, et al. Endothelial dysfunction in glaucoma. Acta Ophthalmol 2009;87(1):4-12.

9.    Jennings RB. Historical perspective on the pathology of myocardial ischemia/reperfusion injury. Circ Res 2013;113(4):428-38.

10.  Pundik S, Xu K, Sundararajan S. Reperfusion brain injury: focus on cellular bioenergetics. Neurology 2012;79(13 Suppl 1):S44-51.

11.  Kaur S, Jaggi AS, Singh N. Molecular aspects of ischaemic postconditioning. Fundam Clin Pharmacol 2009;23(5):521-36.

12.  Mozaffarieh M, Flammer J. New insights in the pathogenesis and treatment of normal tension glaucoma. Curr Opin Pharmacol 2013;13(1):43-9.

13.  Leung DY, Li FC, Kwong YY, et al. Simvastatin and disease stabilization in normal tension glaucoma: a cohort study. Ophthalmology 2010;117(3):471-6.

14.  Koseki N, Araie M, Tomidokoro A, et al. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure. Ophthalmology 2008;115(11):2049-57.

15.  Kim M, Kim DM, Park KH, et al. Intraocular pressure reduction with topical medications and progression of normal-tension glaucoma: a 12-year mean follow-up study. Acta Ophthalmol 2013;91(4):e270-5.

16.  Harris A, Topouzis F, Wilson MR, et al. Association of the optic disc structure with the use of antihypertensive medications: the thessaloniki eye study. J Glaucoma 2013: 22(7):526-31

17.  Khawaja AP, Chan MP, Broadway DC, et al. Systemic medication and intraocular pressure in a British population: the EPIC-Norfolk Eye Study. Ophthalmology 2014: 121(8):1501-7

18.  Muskens RP, de Voogd S, Wolfs RC. Systemic antihypertensive medication and incident open-angle glaucoma. Ophthalmology 2007: 114(12):2221-6

19.  Gugleta K, Orgül S, Stümpfig D, et al. Fludrocortisone in the treatment of systemic hypotension in primary open-angle glaucoma patients. Int Ophthalmol 1999;23(1):25-30.

20.  Orgul S, Zawinka C, Gugleta K, Flammer J. Therapeutic strategies for normal-tension glaucoma. Ophthalmologica 2005;219(6):317-23.

21.  Gherghel D, Orgül S, Gugleta K, Flammer J. Retrobulbar blood flow in glaucoma patients with nocturnal over-dipping in systemic blood pressure. Am J Ophthalmol 2001;132(5):641-7.

22.  Gherghel D, Hosking SL, Armstrong R, Cunliffe IA. Autonomic dysfunction in unselected and untreated primary open angle glaucoma patients: a pilot study. Ophthalmic Physiol Opt 2007;27(4):336-41.

 

 

 

4th Edition - May 2017